FMP
NASDAQ
3.9 USD
0.05 (1.28%)
Mr. Richard S. Eiswirth Jr.
Healthcare
Drug Manufacturers - Specialty & Generic
https://alimerasciences.com
NASDAQ
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and ...
0001267602
US0162592028
016259202
6310 Town Square
678 990 5740
US
154
Nov 4, 2019
0001267602
NASDAQ
Drug Manufacturers -...
Healthcare
016259202
US0162592028
US
3.9
1.16
83.83k
204.18M
-
1.56-4.38
7.47
-
-
-
-
-4.64
-
https://alimerasciences.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.